4xua: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='4xua' size='340' side='right'caption='[[4xua]], [[Resolution|resolution]] 1.75Å' scene=''> | <StructureSection load='4xua' size='340' side='right'caption='[[4xua]], [[Resolution|resolution]] 1.75Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4xua]] is a 1 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4xua]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XUA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4XUA FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=43C:4-{1-[2-(4-METHYL-1H-1,2,3-TRIAZOL-1-YL)ETHYL]-4-PHENYL-1H-IMIDAZOL-5-YL}BENZONITRILE'>43C</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=43C:4-{1-[2-(4-METHYL-1H-1,2,3-TRIAZOL-1-YL)ETHYL]-4-PHENYL-1H-IMIDAZOL-5-YL}BENZONITRILE'>43C</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4xua FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xua OCA], [https://pdbe.org/4xua PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4xua RCSB], [https://www.ebi.ac.uk/pdbsum/4xua PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4xua ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/BAZ2B_HUMAN BAZ2B_HUMAN] May play a role in transcriptional regulation interacting with ISWI. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 26: | Line 25: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Arrowsmith | [[Category: Arrowsmith CH]] | ||
[[Category: Bountra | [[Category: Bountra C]] | ||
[[Category: Chaikuad | [[Category: Chaikuad A]] | ||
[[Category: Edwards AM]] | |||
[[Category: Edwards | [[Category: Felletar I]] | ||
[[Category: Felletar | [[Category: Knapp S]] | ||
[[Category: Knapp | [[Category: Von Delft F]] | ||
[[Category: | |||
Revision as of 20:52, 26 April 2023
Crystal Structure of the bromodomain of human BAZ2B in complex with E11919 BAZ2-ICR analogueCrystal Structure of the bromodomain of human BAZ2B in complex with E11919 BAZ2-ICR analogue
Structural highlights
FunctionBAZ2B_HUMAN May play a role in transcriptional regulation interacting with ISWI. Publication Abstract from PubMedThe bromodomain containing proteins BAZ2A/B play essential roles in chromatin remodeling and regulation of noncoding RNAs. We present the structure based discovery of a potent, selective, and cell active inhibitor 13 (BAZ2-ICR) of the BAZ2A/B bromodomains through rapid optimization of a weakly potent starting point. A key feature of the presented inhibitors is an intramolecular aromatic stacking interaction that efficiently occupies the shallow bromodomain pockets. 13 represents an excellent chemical probe for functional studies of the BAZ2 bromodomains in vitro and in vivo. Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B.,Drouin L, McGrath S, Vidler LR, Chaikuad A, Monteiro O, Tallant C, Philpott M, Rogers C, Fedorov O, Liu M, Akhtar W, Hayes A, Raynaud F, Muller S, Knapp S, Hoelder S J Med Chem. 2015 Feb 26. PMID:25719566[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||